Germany: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Getting Ready For The EU Pharma Package Part 3: Accelerating Drug Development And Authorization

From expanded approaches to scientific advice and a shift away from animal testing to new frameworks for platform technologies...

European Union Healthcare

AO

A&O Shearman

Getting Ready For The EU Pharma Package Part 2: Stricter Rules On Environmental Risk Assessment – Everything You Need To Know

After the Council and the European Parliament have reached an agreement in the trilogue negotiations on the so-called Pharma Package in December 2025...

European Union Healthcare

AO

A&O Shearman

Getting Ready For The EU Pharma Package: Key Changes To Regulatory Exclusivities, Orphan Medicinal Products And The “Bolar” Exemption Provisions

After the Council and the European Parliament have reached an agreement in the trilogue negotiations on the so-called Pharma Package in December 2025, the texts of the provisional agreement (comprising a new regulation and a new directive) have now been published.

European Union Healthcare

AO

A&O Shearman

Bundesgerichtshof setzt neue Maßstäbe bei der Einschränkung von EU-Freiheiten in Zivilverfahren

Der Bundesgerichtshof (BGH) hat in einer Grundsatzentscheidung (I ZR 74/24 – Arzneimittel-Check) entschieden, dass nationale Gerichte auch in Streitigkeiten zwischen privaten...

Germany Healthcare

GT

Greenberg Traurig, LLP

EU Commission Proposes Much Anticipated MDR And IVDR Revision

Germany Healthcare

AO

A&O Shearman

EU Pharma Package: Parliament And Council Reach Agreement To Modernize EU Pharmaceutical Legislation—Key Takeaways For Pharma

European Union Healthcare

AO

A&O Shearman

Europe's Pharma Reform: How The Discussion Affects Strategic Decisions Today

European Union Healthcare

MB

Mayer Brown

European Biosimilar Updates – Formycon's Ustekinumab And Alvotech's Cetrolizumab Pegol

Germany Healthcare

GP

Goodwin Procter LLP

EU Commission Consultation On High-Risk AI Systems: Key Points For Life Sciences And Health Care

European Union Healthcare

GT

Greenberg Traurig, LLP

Second Medical Use Claims In The UPC System: Prerequisites And Mechanism Of Examination For Infringement

Germany Healthcare

BP

Bardehle Pagenberg

New German Government: Key Plans For The Life Sciences And Healthcare Sector

Germany Healthcare

AO

A&O Shearman

New CJEU Ruling On The Borderline Between Medicinal Products And Medical Devices: Key Takeaways

Germany Healthcare

AO

A&O Shearman

Wind Of Change - Are Medical Sick Leave Certificates Still Untouchable?

Germany Healthcare

L

Littler

Key Regulatory Changes Impacting The Healthcare Industry In The EU And Germany In 2025

European Union Healthcare

AO

A&O Shearman

Jason Adelstone To Attend The International Cannabis Business Conference In Berlin

Germany Cannabis

HS

Harris Sliwoski

Court Of Appeal, March 10, 2026, Order, Retroactive Time Extension Under R. 9.3(a) RoP – UPC_CoA_37/2026

BP

Bardehle Pagenberg

ECJ C-51/25: Clarifying The Interpretation Of Payment Services?

Germany Finance

AO

A&O Shearman

ESMA's Record Fine On Governance And Control Failings Signals New Era Of Supervision

Germany Commercial

PL

PwC Legal Germany

Are Company Directors Liable For Patent Infringements? (2025) (Video)

BP

Bardehle Pagenberg

See more

Food and Drugs Law

Getting Ready For The EU Pharma Package Part 3: Accelerating Drug Development And Authorization

From expanded approaches to scientific advice and a shift away from animal testing to new frameworks for platform technologies...

European Union Healthcare

AO

A&O Shearman

Bundesgerichtshof setzt neue Maßstäbe bei der Einschränkung von EU-Freiheiten in Zivilverfahren

Der Bundesgerichtshof (BGH) hat in einer Grundsatzentscheidung (I ZR 74/24 – Arzneimittel-Check) entschieden, dass nationale Gerichte auch in Streitigkeiten zwischen privaten...

Germany Healthcare

GT

Greenberg Traurig, LLP

The UPC's Emerging Approach To Injunctions: Patterns, Pitfalls, And Global Implications

Since its entry into force on June 1, 2023, the Unified Patent Court (UPC) has seen a growing number of cases across various fields, including pharmaceuticals, biotechnology...

SR

McDermott Will & Schulte

EU Pharma Package: Parliament And Council Reach Agreement To Modernize EU Pharmaceutical Legislation—Key Takeaways For Pharma

European Union Healthcare

AO

A&O Shearman

A&M Germany Valuation Insights

Germany Commercial

AM

Alvarez & Marsal

Europe's Pharma Reform: How The Discussion Affects Strategic Decisions Today

European Union Healthcare

MB

Mayer Brown

Herbert Smith Freehills Kramer Comments For LSIPR On Small Molecule Litigation In The UPC

KL

Herbert Smith Freehills Kramer LLP

Second Medical Use Claims At The UPC: What Are The Infringement Prerequisites And Legal Standards? (Video)

BP

Bardehle Pagenberg

European Biosimilar Updates – Formycon's Ustekinumab And Alvotech's Cetrolizumab Pegol

Germany Healthcare

GP

Goodwin Procter LLP

See more

Life Sciences, Biotechnology & Nanotechnology

Getting Ready For The EU Pharma Package Part 3: Accelerating Drug Development And Authorization

From expanded approaches to scientific advice and a shift away from animal testing to new frameworks for platform technologies...

European Union Healthcare

AO

A&O Shearman

Getting Ready For The EU Pharma Package Part 2: Stricter Rules On Environmental Risk Assessment – Everything You Need To Know

After the Council and the European Parliament have reached an agreement in the trilogue negotiations on the so-called Pharma Package in December 2025...

European Union Healthcare

AO

A&O Shearman

For Medical Devices, “Possible Use” Amounts To Infringement Only If The Use Is In Line With Medical Practice

The UPC Munich Local Division (the LD Munich) has dismissed an infringement action relating to a medical device. It confirmed that a device can still infringe a patent, even if it is normally operated in a non-infringing way, as long as the patent-infringing use remains possible.

AO

A&O Shearman

Getting Ready For The EU Pharma Package: Key Changes To Regulatory Exclusivities, Orphan Medicinal Products And The “Bolar” Exemption Provisions

European Union Healthcare

AO

A&O Shearman

UPC Structure – Local, Regional And Central Divisions And Court Of Appeal, Judges & Languages

KL

Herbert Smith Freehills Kramer LLP

The UPC's Emerging Approach To Injunctions: Patterns, Pitfalls, And Global Implications

SR

McDermott Will & Schulte

EU Commission Proposes Much Anticipated MDR And IVDR Revision

Germany Healthcare

AO

A&O Shearman

How Germany's Chemical And Pharmaceutical Industry Is Competing Globally

AM

Alvarez & Marsal

Europe's Pharma Reform: How The Discussion Affects Strategic Decisions Today

European Union Healthcare

MB

Mayer Brown

See more

Healthcare

Getting Ready For The EU Pharma Package Part 3: Accelerating Drug Development And Authorization

From expanded approaches to scientific advice and a shift away from animal testing to new frameworks for platform technologies...

European Union Healthcare

AO

A&O Shearman

Getting Ready For The EU Pharma Package Part 2: Stricter Rules On Environmental Risk Assessment – Everything You Need To Know

After the Council and the European Parliament have reached an agreement in the trilogue negotiations on the so-called Pharma Package in December 2025...

European Union Healthcare

AO

A&O Shearman

Bundesgerichtshof setzt neue Maßstäbe bei der Einschränkung von EU-Freiheiten in Zivilverfahren

Der Bundesgerichtshof (BGH) hat in einer Grundsatzentscheidung (I ZR 74/24 – Arzneimittel-Check) entschieden, dass nationale Gerichte auch in Streitigkeiten zwischen privaten...

Germany Healthcare

GT

Greenberg Traurig, LLP

The UPC's Emerging Approach To Injunctions: Patterns, Pitfalls, And Global Implications

SR

McDermott Will & Schulte

A&M Germany Valuation Insights

Germany Commercial

AM

Alvarez & Marsal

Europe's Pharma Reform: How The Discussion Affects Strategic Decisions Today

European Union Healthcare

MB

Mayer Brown

Second Medical Use Claims At The UPC: What Are The Infringement Prerequisites And Legal Standards? (Video)

BP

Bardehle Pagenberg

Konsultation der EU-Kommission zu Hochrisiko-KI-Systemen: Kernpunkte für den Life Sciences- und Health Care-Sektor

Germany Technology

GT

Greenberg Traurig, LLP

EU Commission Consultation On High-Risk AI Systems: Key Points For Life Sciences And Health Care

European Union Healthcare

GT

Greenberg Traurig, LLP

See more

Latest Videos

See more

Healthy Byte | Live From HIMSS 25! (Video)

AB

Alston & Bird

Ile Wynosi Zadłużenie Szpitali?

KHG Hupajlo Grzegorczyk & Partners

Lex Inside - L'Actualité Juridique - Émission Du 28 Juin 2024 (Video)

J

Jeantet

Episode #12 | European Health Data Space Regulation | 1 December 2022 (Video)

AM

Arendt & Medernach

What Regulatory Challenges Are Facing The Life Sciences Sector? (Video)

WF

William Fry

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More